Las Vegas, NV (PRWEB) October 31, 2013
EQ Biosciences, Inc. is the manufacturer and marketing company for the patented proprietary dietary supplement, Prevennia®, which has shown significant results in assisting the body in preventing the formation of estrogen DNA adducts which can cause damage to the DNA and lead to serious illness.
Over 600 peer-reviewed studies have been published in many prestigious and reputable scientific journals by the lead authors, Dr. Rogan and Dr. Cavalieri.
Many of these can be found at the National Institute of Health’s (NIH) web site (1). Additionally, the pioneering work by Dr. Cavalieri and Rogan delineating estrogen metabolism as one of the two accepted mechanisms of estrogen carcinogenesis has appeared in a January 2006 “Mechanisms of Disease” review in the New England Journal of Medicine by Drs. Davidson and Yager.
“It was decided the time had come to make Prevennia® available to the general public,” stated Julio F. Varela, VP of Business Development. “We have scientific validation that Prevennia® can help people protect their bodies against numerous diseases.”
David Westbrock MD and a certified member of the American Board of Internal Medicine in Internal Medicine and Endocrinology/Metabolism has this to say about Prevennia, “Prevennia by far exceeds anything on the market today in helping to balance estrogen metabolism in both men and women.”
Media inquiries are invited.
Additional information including scientific research studies can be found by clicking HERE.
To order Prevennia® with a discount use the promo code “SAVE” and click on Prevennia Amazing Health Discovery.
ABOUT THE COMPANY
EQ Biosciences, Inc. is a Nevada C Corporation formed to manufacture and market an exciting proprietary dietary supplement, Prevennia®, which credible scientific research has shown will assist the human body in preventing the initiation of various diseases. EQ Biosciences, Inc. also provides funding to their scientists to aid their continuing research in broadening the scope for verified applications of Prevennia®
EQ Biosciences, Inc.’s scientists have been engaged in cancer research since the late 1960s. Their work has been reviewed, published, critiqued, and accepted by their peers in the scientific community and has led to the granting of patents on the testing procedures, and a patent on the uses of Prevennia® in a wide variety of areas.
Research has shown that when the body’s estrogen metabolism is unbalanced, the estrogen metabolites can react with DNA and thereby are prone to start the process leading to mutations in cells. Renowned scientists Dr. Ercole Cavalieri and Dr. Eleanor Rogan, who have been involved with these scientific findings and research for more than four decades, have published their findings in the following journals: International Journal of Cancer; Cancer Prevention Research; Breast Cancer: Basic and Clinical Research; Prostate; Journal of Steroid Biochemistry and Molecular Biology; Future Oncology.
Prevennia®, when taken on a regular basis, will assist the body in preventing the formation of estrogen DNA adducts which can cause damage to DNA, thus starting a cell on its way to forming or initiating breast or prostate cancer.
1. National Institute of Health; ncbi.nlm.nih.gov/pubmed/23843041; July 10, 2013